TheraRadar
← Back
Data updated: Mar 29, 2026

TONIX

NeurologyInfectious Disease
Pharma

TONIX is a pharmaceutical company focused on Neurology, Infectious Disease. Key products include TONMYA.

2025
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

TONMYA
cyclobenzaprine hydrochloride
5-HT2A 1 indications · 2025

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

TONMYA 2025-08-15
Type 3 - New Dosage Form
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 50%
0 drugs Phase 2: 1
Infectious Disease 50%
0 drugs Phase 2: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

AbbVie big-pharma
Neurology, Infectious Disease
GSK big-pharma
Infectious Disease, Neurology
Bristol-Myers Squibb big-pharma
Infectious Disease, Neurology
GE HEALTHCARE specialty
Infectious Disease, Neurology
Novo Nordisk big-pharma
Infectious Disease, Neurology